Loading stock…

Ipsen S.A. (IPN) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

IPNIpsen S.A.

Revenue FY25$4.6B

GROWTH RATING↗

AVERAGE55 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+11%7

Revenue, next 1Y+12%7

Revenue, next 3Y, CAGR+8%6

Revenue, next 5Y, CAGR+5%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+174%10

EPS growth, FY27E-9%3

EPS growth, FY28E-2%3

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 11%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

WATCH

A mid-pack grower, ahead of 55% of companies worldwide.

Revenue is set to grow 8%/yr over the next 3 years, a little ahead of the market.6/10

Revenue grew 11%/yr over the last 3 years; forecasts see it cooling to 8%/yr.

Over five years revenue is set to grow 5%/yr, about average versus companies worldwide.5/10

WEAKNESSES

Earnings are set to fall even as revenue grows (EPS about -2%/yr vs revenue 8%/yr).

BOTTOM LINE

Maturing Grower

A middle-of-the-pack grower that is slowing. The one thing to watch: earnings are forecast to fall.

03Price Momentum

Is the market behind it right now?

IPNIpsen S.A.

Total return Current143%

Price return Current119%

MOMENTUM RATING↗

WEAK28 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-15%1

3-month return-17%2

YTD return+18%7

MID & LONG-TERM▾SCORE

% of 52-week high81%5

1-year return+21%7

3-year return+18%4

5-year return+72%7

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming so far this year (+18%).

WATCH

Average long-term results. Multi-year returns are middling (+18% over three years and +72% over five), roughly average for the market.

It's up 21% over the past year, but 19% below its 52-week high. That is a touch ahead of the market.

WEAKNESSES

The stock is underperforming over the past month (-15%) and over three months (-17%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the stock is underperforming over the past month and over three months.

04Value

Are you paying a fair price for it?

Stop guessing on Ipsen. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

IPNIpsen S.A.

Revenue FY25$4.6B

GROWTH RATING↗

AVERAGE55 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+11%7

Revenue, next 1Y+12%7

Revenue, next 3Y, CAGR+8%6

Revenue, next 5Y, CAGR+5%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+174%10

EPS growth, FY27E-9%3

EPS growth, FY28E-2%3

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 11%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

WATCH

A mid-pack grower, ahead of 55% of companies worldwide.

Revenue is set to grow 8%/yr over the next 3 years, a little ahead of the market.6/10

Revenue grew 11%/yr over the last 3 years; forecasts see it cooling to 8%/yr.

Over five years revenue is set to grow 5%/yr, about average versus companies worldwide.5/10

WEAKNESSES

Earnings are set to fall even as revenue grows (EPS about -2%/yr vs revenue 8%/yr).

BOTTOM LINE

Maturing Grower

A middle-of-the-pack grower that is slowing. The one thing to watch: earnings are forecast to fall.

03Price Momentum

Is the market behind it right now?

IPNIpsen S.A.

Total return Current143%

Price return Current119%

MOMENTUM RATING↗

WEAK28 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-15%1

3-month return-17%2

YTD return+18%7

MID & LONG-TERM▾SCORE

% of 52-week high81%5

1-year return+21%7

3-year return+18%4

5-year return+72%7

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming so far this year (+18%).

WATCH

Average long-term results. Multi-year returns are middling (+18% over three years and +72% over five), roughly average for the market.

It's up 21% over the past year, but 19% below its 52-week high. That is a touch ahead of the market.

WEAKNESSES

The stock is underperforming over the past month (-15%) and over three months (-17%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Ipsen. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Ipsen S.A.

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Ipsen. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Ipsen. Get the full investment case.

Premium